SCHEMBL16619692

SCHEMBL16619692

CCOC(=O)c1ccc(CC2CCC(C(O)c3cccc(Cl)c3)N2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43
ALDH1A1 P00352 2/20 0.38
TRPV1 Q8NER1 1/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MDM2 Q00987 3/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
NPY2R P49146 1/20 0.35
ADRB3 P13945 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17986590 1.00 TP53 (0.43) TP53POLBALDH1A1TRPV1MEN1
SCHEMBL17986588 1.00 TP53 (0.43) TP53POLBALDH1A1TRPV1MEN1
SCHEMBL16619243 0.90 ADRB3 (0.40) ADRB3
SCHEMBL16619242 0.90 ADRB3 (0.40) ADRB3
SCHEMBL17986554 0.87 STS (0.36) TP53POLBALDH1A1SMN1; SMN2ADRB3
SCHEMBL21268160 0.87 STS (0.36) TP53POLBALDH1A1SMN1; SMN2ADRB3
SCHEMBL16619599 0.87 STS (0.36) TP53POLBALDH1A1SMN1; SMN2ADRB3
SCHEMBL21268162 0.87 STS (0.36) TP53POLBALDH1A1SMN1; SMN2ADRB3
SCHEMBL16619997 0.87 STS (0.36) TP53POLBLMNASMN1; SMN2
SCHEMBL17986570 0.87 STS (0.36) TP53POLBLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052099-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS Merck Sharp & Dohme Corp. (US) 2016-08-10 EP disclosed
WO-2015050798-A1 NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2015-04-09 WO disclosed